Edoxaban, a Factor Xa-Specific Direct Oral Anticoagulant, Significantly Suppresses Tumor Growth in Colorectal Cancer Colon26-Inoculated BALB/c Mice

Keiichi Hiramoto(Suzuka University of Medical Science), Koji Suzuki(Yokohama City University Medical Center), Junji Nishioka(Mie University), Nobuyuki Akita(Suzuka University of Medical Science)
TH Open
January 1, 2023
Cited by 16


Related Papers